Qualified Omega-3 Fatty Acid Health Claim Proposed By Industry Group
This article was originally published in The Tan Sheet
Executive Summary
A qualified health claim concerning the relationship between omega-3 fatty acids and a reduced risk for coronary heart disease should be cleared by FDA, a joint industry group states in Nov. 21 comments to the agency.
You may also be interested in...
NCCAM Omega-3 Fatty Acids Study To Commence In April
The National Institutes of Health is sponsoring several clinical trials on omega-3 fatty acids, including one investigating their effect on major depression and bipolar disorder and another studying fatty acids' antiarrhythmic effects.
NCCAM Omega-3 Fatty Acids Study To Commence In April
The National Institutes of Health is sponsoring several clinical trials on omega-3 fatty acids, including one investigating their effect on major depression and bipolar disorder and another studying fatty acids' antiarrhythmic effects.
NCCAM Omega-3 Fatty Acids Study To Commence In April
The National Institutes of Health is sponsoring several clinical trials on omega-3 fatty acids, including one investigating their effect on major depression and bipolar disorder and another studying fatty acids' antiarrhythmic effects.